Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Estimated Value: $1,000,000
Open 536 days left Healthcaregrant
Nov 22, 2024
Dec 23, 2027 12:00 AM
Healthcare
grant
AI Summary
This grant opportunity (RFA-HL-26-018) from NIH supports preliminary product/lead series identification and combination product prototype development for small molecules, biologics, and combination products. It is an R33 grant, and clinical trials are not allowed.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Product Definition Services for Small Molecules 1 project $250,000.00 $250,000.00 Professional Services
Product Definition Services for Biologics 1 project $250,000.00 $250,000.00 Professional Services
Product Definition Services for Combination Products 1 project $250,000.00 $250,000.00 Professional Services
Combination Product Prototype Development 1 project $250,000.00 $250,000.00 Professional Services
Estimated Bid Value$1,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids